153 related articles for article (PubMed ID: 38195458)
1. Impact of immunohistochemical expression of kinesin family member 18A (Kif18A) and β-catenin in infiltrating breast carcinoma of no special type.
Hemida AS; Shabaan MI; Taha MA; Abdou AG
World J Surg Oncol; 2024 Jan; 22(1):15. PubMed ID: 38195458
[TBL] [Abstract][Full Text] [Related]
2. High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.
Li X; Liu M; Zhang Z; Zhang L; Liang X; Sun L; Zhong D
Thorac Cancer; 2019 May; 10(5):1103-1110. PubMed ID: 30907518
[TBL] [Abstract][Full Text] [Related]
3. Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
Alfarsi LH; Elansari R; Toss MS; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2019 Jan; 173(1):93-102. PubMed ID: 30306428
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological relevance of kinesin family member 18A expression in invasive breast cancer.
Kasahara M; Nagahara M; Nakagawa T; Ishikawa T; Sato T; Uetake H; Sugihara K
Oncol Lett; 2016 Sep; 12(3):1909-1914. PubMed ID: 27588139
[TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of Nek2 and β-catenin in breast carcinoma: clinicopathological correlations.
Wang S; Li W; Lv S; Wang Y; Liu Z; Zhang J; Liu T; Niu Y
Histopathology; 2011 Oct; 59(4):631-42. PubMed ID: 22014044
[TBL] [Abstract][Full Text] [Related]
6. Kinesin Family Member 18A (KIF18A) Contributes to the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells In Vitro and In Vivo.
Chen FT; Zhong FK
Dis Markers; 2019; 2019():6383685. PubMed ID: 31772692
[TBL] [Abstract][Full Text] [Related]
7. Kif18A is involved in human breast carcinogenesis.
Zhang C; Zhu C; Chen H; Li L; Guo L; Jiang W; Lu SH
Carcinogenesis; 2010 Sep; 31(9):1676-84. PubMed ID: 20595236
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of β-catenin in invasive ductal breast carcinomas.
Abd El-Rehim D; Ali MM
J Egypt Natl Canc Inst; 2009 Jun; 21(2):185-95. PubMed ID: 21057570
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of KIF18A enhances cell proliferation and predicts poor survival in human clear cell renal carcinoma.
Chen QI; Cao B; Nan N; Wang YU; Zhai XU; Li Y; Chong T
Exp Ther Med; 2016 Jul; 12(1):377-383. PubMed ID: 27347065
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
[TBL] [Abstract][Full Text] [Related]
12. Stromal CD10 expression and relationship to the E-cadherin/beta-catenin complex in breast carcinoma.
Kim HS; Kim GY; Kim YW; Park YK; Song JY; Lim SJ
Histopathology; 2010 May; 56(6):708-19. PubMed ID: 20546336
[TBL] [Abstract][Full Text] [Related]
13.
Liu Y; Sun M; Zhang B; Zhao W
Aging (Albany NY); 2023 Sep; 15(17):9182-9192. PubMed ID: 37708299
[TBL] [Abstract][Full Text] [Related]
14. Transducin (β)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling.
Li X; Liang W; Liu J; Lin C; Wu S; Song L; Yuan Z
Breast Cancer Res; 2014 Oct; 16(5):465. PubMed ID: 25341494
[TBL] [Abstract][Full Text] [Related]
15. Silencing of KIF18B restricts proliferation and invasion and enhances the chemosensitivity of breast cancer via modulating Akt/GSK-3β/β-catenin pathway.
Jiang J; Liu T; He X; Ma W; Wang J; Zhou Q; Li M; Yu S
Biofactors; 2021 Sep; 47(5):754-767. PubMed ID: 34058791
[TBL] [Abstract][Full Text] [Related]
16. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
Lim SC; Lee MS
Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients.
López-Knowles E; Zardawi SJ; McNeil CM; Millar EK; Crea P; Musgrove EA; Sutherland RL; O'Toole SA
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):301-9. PubMed ID: 20056651
[TBL] [Abstract][Full Text] [Related]
18. Loss of FAT1 during the progression from DCIS to IDC and predict poor clinical outcome in breast cancer.
Wang L; Lyu S; Wang S; Shen H; Niu F; Liu X; Liu J; Niu Y
Exp Mol Pathol; 2016 Feb; 100(1):177-83. PubMed ID: 26721716
[TBL] [Abstract][Full Text] [Related]
19. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
[TBL] [Abstract][Full Text] [Related]
20. Expression of KIF18A Is Associated with Increased Tumor Stage and Cell Proliferation in Prostate Cancer.
Zhang H; Shen T; Zhang Z; Li Y; Pan Z
Med Sci Monit; 2019 Aug; 25():6418-6428. PubMed ID: 31451680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
